Loading…
Combined PCI and minimally invasive heart valve surgery for high-risk patients
Opinion statement Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surg...
Saved in:
Published in: | Current treatment options in cardiovascular medicine 2009-12, Vol.11 (6), p.492-498 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333 |
---|---|
cites | cdi_FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333 |
container_end_page | 498 |
container_issue | 6 |
container_start_page | 492 |
container_title | Current treatment options in cardiovascular medicine |
container_volume | 11 |
creator | Umakanthan, Ramanan Leacche, Marzia Petracek, Michael R. Zhao, David X. Byrne, John G. |
description | Opinion statement
Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surgery using a median sternotomy and cardiopulmonary bypass. With the increasing complexity of patients referred to surgery, some patients may prove to be poor surgical candidates for combined valve and CABG surgery. In certain selected patients who fall into this category, valve surgery and percutaneous coronary intervention (PCI) have been considered a feasible alternative. Conventionally, valve surgery is performed in the cardiac surgical operating room, whereas PCI is carried out in the cardiac catheterization laboratory. Separation of these two procedural suites has presented a logistic limitation because it impedes the concomitant performance of both procedures in one setting. Hence, PCI and valve surgery usually have been performed as a “two-stage” procedure in two different operative suites, with the procedures being separated by hours, days, or weeks. Technologic advancements have made possible the construction of a “hybrid” procedural suite that combines the facilities of a cardiac surgical operating room with those of a cardiac catheterization laboratory. This design has enabled the concept of “one-stage” or “one-stop” PCI and valve surgery, allowing both procedures to be performed in a hybrid suite in one setting, separated by minutes. The advantages of such a method could prove to be multifold by enabling a less invasive surgical approach and improving logistics, patient satisfaction, and outcomes in selected patients. |
doi_str_mv | 10.1007/s11936-009-0052-2 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733562273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2919734346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMobk5_gDcS8MKrak7SpsmlFD8GQ73Q65C26ZbZj5m0g_17MzoYCF6EnJDnvOfwIHQN5B4ISR88gGQ8IkSGk9CInqApJCyOGAh5GmoiaSRiHk_QhfdrQmjChDhHE5CSESnSKXrLuia3rSnxRzbHui1xY1vb6LreYdtutbdbg1dGux5vdR1qP7ilcTtcdQ6v7HIVOeu_8Ub31rS9v0Rnla69uTrcM_T1_PSZvUaL95d59riICio4jVgCUpRlIgqdl9RURsoyAR4TWZKYQ3iG1YEXAFSK3BBS6VQISYimkgNjbIbuxtyN634G43vVWF-Yutat6QavUsYSTmm6J2__kOtucG1YTlEJMmUxi3mgYKQK13nvTKU2LlhwOwVE7V2r0bUKrtXetaKh5-aQPOSNKY8dB7kBoCPgw1cbrB1H_5_6C2zAh0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2919734346</pqid></control><display><type>article</type><title>Combined PCI and minimally invasive heart valve surgery for high-risk patients</title><source>Springer Nature</source><creator>Umakanthan, Ramanan ; Leacche, Marzia ; Petracek, Michael R. ; Zhao, David X. ; Byrne, John G.</creator><creatorcontrib>Umakanthan, Ramanan ; Leacche, Marzia ; Petracek, Michael R. ; Zhao, David X. ; Byrne, John G.</creatorcontrib><description>Opinion statement
Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surgery using a median sternotomy and cardiopulmonary bypass. With the increasing complexity of patients referred to surgery, some patients may prove to be poor surgical candidates for combined valve and CABG surgery. In certain selected patients who fall into this category, valve surgery and percutaneous coronary intervention (PCI) have been considered a feasible alternative. Conventionally, valve surgery is performed in the cardiac surgical operating room, whereas PCI is carried out in the cardiac catheterization laboratory. Separation of these two procedural suites has presented a logistic limitation because it impedes the concomitant performance of both procedures in one setting. Hence, PCI and valve surgery usually have been performed as a “two-stage” procedure in two different operative suites, with the procedures being separated by hours, days, or weeks. Technologic advancements have made possible the construction of a “hybrid” procedural suite that combines the facilities of a cardiac surgical operating room with those of a cardiac catheterization laboratory. This design has enabled the concept of “one-stage” or “one-stop” PCI and valve surgery, allowing both procedures to be performed in a hybrid suite in one setting, separated by minutes. The advantages of such a method could prove to be multifold by enabling a less invasive surgical approach and improving logistics, patient satisfaction, and outcomes in selected patients.</description><identifier>ISSN: 1092-8464</identifier><identifier>EISSN: 1534-3189</identifier><identifier>DOI: 10.1007/s11936-009-0052-2</identifier><identifier>PMID: 19930987</identifier><language>eng</language><publisher>New York: Current Science Inc</publisher><subject>Cardiac catheterization ; Cardiology ; Coronary vessels ; Intubation ; Medicine ; Medicine & Public Health ; Patient satisfaction ; Surgery</subject><ispartof>Current treatment options in cardiovascular medicine, 2009-12, Vol.11 (6), p.492-498</ispartof><rights>Current Medicine Group, LLC 2009</rights><rights>Current Medicine Group, LLC 2009.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333</citedby><cites>FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19930987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Umakanthan, Ramanan</creatorcontrib><creatorcontrib>Leacche, Marzia</creatorcontrib><creatorcontrib>Petracek, Michael R.</creatorcontrib><creatorcontrib>Zhao, David X.</creatorcontrib><creatorcontrib>Byrne, John G.</creatorcontrib><title>Combined PCI and minimally invasive heart valve surgery for high-risk patients</title><title>Current treatment options in cardiovascular medicine</title><addtitle>Curr Treat Options Cardio Med</addtitle><addtitle>Curr Treat Options Cardiovasc Med</addtitle><description>Opinion statement
Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surgery using a median sternotomy and cardiopulmonary bypass. With the increasing complexity of patients referred to surgery, some patients may prove to be poor surgical candidates for combined valve and CABG surgery. In certain selected patients who fall into this category, valve surgery and percutaneous coronary intervention (PCI) have been considered a feasible alternative. Conventionally, valve surgery is performed in the cardiac surgical operating room, whereas PCI is carried out in the cardiac catheterization laboratory. Separation of these two procedural suites has presented a logistic limitation because it impedes the concomitant performance of both procedures in one setting. Hence, PCI and valve surgery usually have been performed as a “two-stage” procedure in two different operative suites, with the procedures being separated by hours, days, or weeks. Technologic advancements have made possible the construction of a “hybrid” procedural suite that combines the facilities of a cardiac surgical operating room with those of a cardiac catheterization laboratory. This design has enabled the concept of “one-stage” or “one-stop” PCI and valve surgery, allowing both procedures to be performed in a hybrid suite in one setting, separated by minutes. The advantages of such a method could prove to be multifold by enabling a less invasive surgical approach and improving logistics, patient satisfaction, and outcomes in selected patients.</description><subject>Cardiac catheterization</subject><subject>Cardiology</subject><subject>Coronary vessels</subject><subject>Intubation</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Patient satisfaction</subject><subject>Surgery</subject><issn>1092-8464</issn><issn>1534-3189</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp1kF1LwzAUhoMobk5_gDcS8MKrak7SpsmlFD8GQ73Q65C26ZbZj5m0g_17MzoYCF6EnJDnvOfwIHQN5B4ISR88gGQ8IkSGk9CInqApJCyOGAh5GmoiaSRiHk_QhfdrQmjChDhHE5CSESnSKXrLuia3rSnxRzbHui1xY1vb6LreYdtutbdbg1dGux5vdR1qP7ilcTtcdQ6v7HIVOeu_8Ub31rS9v0Rnla69uTrcM_T1_PSZvUaL95d59riICio4jVgCUpRlIgqdl9RURsoyAR4TWZKYQ3iG1YEXAFSK3BBS6VQISYimkgNjbIbuxtyN634G43vVWF-Yutat6QavUsYSTmm6J2__kOtucG1YTlEJMmUxi3mgYKQK13nvTKU2LlhwOwVE7V2r0bUKrtXetaKh5-aQPOSNKY8dB7kBoCPgw1cbrB1H_5_6C2zAh0A</recordid><startdate>200912</startdate><enddate>200912</enddate><creator>Umakanthan, Ramanan</creator><creator>Leacche, Marzia</creator><creator>Petracek, Michael R.</creator><creator>Zhao, David X.</creator><creator>Byrne, John G.</creator><general>Current Science Inc</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200912</creationdate><title>Combined PCI and minimally invasive heart valve surgery for high-risk patients</title><author>Umakanthan, Ramanan ; Leacche, Marzia ; Petracek, Michael R. ; Zhao, David X. ; Byrne, John G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Cardiac catheterization</topic><topic>Cardiology</topic><topic>Coronary vessels</topic><topic>Intubation</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Patient satisfaction</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Umakanthan, Ramanan</creatorcontrib><creatorcontrib>Leacche, Marzia</creatorcontrib><creatorcontrib>Petracek, Michael R.</creatorcontrib><creatorcontrib>Zhao, David X.</creatorcontrib><creatorcontrib>Byrne, John G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Current treatment options in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Umakanthan, Ramanan</au><au>Leacche, Marzia</au><au>Petracek, Michael R.</au><au>Zhao, David X.</au><au>Byrne, John G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined PCI and minimally invasive heart valve surgery for high-risk patients</atitle><jtitle>Current treatment options in cardiovascular medicine</jtitle><stitle>Curr Treat Options Cardio Med</stitle><addtitle>Curr Treat Options Cardiovasc Med</addtitle><date>2009-12</date><risdate>2009</risdate><volume>11</volume><issue>6</issue><spage>492</spage><epage>498</epage><pages>492-498</pages><issn>1092-8464</issn><eissn>1534-3189</eissn><abstract>Opinion statement
Combined coronary artery valvular heart disease is a major cause of morbidity and mortality in the adult patient population. The standard treatment for such disease has been open heart surgery in which coronary artery bypass grafting (CABG) is performed concurrently with valve surgery using a median sternotomy and cardiopulmonary bypass. With the increasing complexity of patients referred to surgery, some patients may prove to be poor surgical candidates for combined valve and CABG surgery. In certain selected patients who fall into this category, valve surgery and percutaneous coronary intervention (PCI) have been considered a feasible alternative. Conventionally, valve surgery is performed in the cardiac surgical operating room, whereas PCI is carried out in the cardiac catheterization laboratory. Separation of these two procedural suites has presented a logistic limitation because it impedes the concomitant performance of both procedures in one setting. Hence, PCI and valve surgery usually have been performed as a “two-stage” procedure in two different operative suites, with the procedures being separated by hours, days, or weeks. Technologic advancements have made possible the construction of a “hybrid” procedural suite that combines the facilities of a cardiac surgical operating room with those of a cardiac catheterization laboratory. This design has enabled the concept of “one-stage” or “one-stop” PCI and valve surgery, allowing both procedures to be performed in a hybrid suite in one setting, separated by minutes. The advantages of such a method could prove to be multifold by enabling a less invasive surgical approach and improving logistics, patient satisfaction, and outcomes in selected patients.</abstract><cop>New York</cop><pub>Current Science Inc</pub><pmid>19930987</pmid><doi>10.1007/s11936-009-0052-2</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1092-8464 |
ispartof | Current treatment options in cardiovascular medicine, 2009-12, Vol.11 (6), p.492-498 |
issn | 1092-8464 1534-3189 |
language | eng |
recordid | cdi_proquest_miscellaneous_733562273 |
source | Springer Nature |
subjects | Cardiac catheterization Cardiology Coronary vessels Intubation Medicine Medicine & Public Health Patient satisfaction Surgery |
title | Combined PCI and minimally invasive heart valve surgery for high-risk patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A33%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20PCI%20and%20minimally%20invasive%20heart%20valve%20surgery%20for%20high-risk%20patients&rft.jtitle=Current%20treatment%20options%20in%20cardiovascular%20medicine&rft.au=Umakanthan,%20Ramanan&rft.date=2009-12&rft.volume=11&rft.issue=6&rft.spage=492&rft.epage=498&rft.pages=492-498&rft.issn=1092-8464&rft.eissn=1534-3189&rft_id=info:doi/10.1007/s11936-009-0052-2&rft_dat=%3Cproquest_cross%3E2919734346%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2862-35198dd58cabd2efe99d516409d0461e9910916c11298be00fa788900a2961333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2919734346&rft_id=info:pmid/19930987&rfr_iscdi=true |